Global arbovirus activity remains high, with chikungunya causing 271,223 cases and 113 deaths outside the EU/EEA this year, primarily in the Americas. Within Europe, France has reported 207 locally acquired cases, while Switzerland confirmed its first-ever local transmission. Dengue activity has shifted toward Asia, notably in Bangladesh, which has recorded 114,251 cases and 352 deaths, while Chad faces a rapidly expanding outbreak. In the United States, measles cases have surged to 5,182, with eight reported deaths, threatening the country's elimination status. Meanwhile, West Africa is experiencing concentrated yellow fever activity, led by Côte d'Ivoire. In Europe, West Nile virus transmission is waning after 2,029 locally acquired cases. Elsewhere, France has noted a surge in extensively drug-resistant typhoid linked to travel from Senegal, and Thailand reports sustained endemic transmission of mpox with 470 cases this year.
Chikungunya, global updates
ECDC has counted 271,223 cases and 113 deaths in 26 countries outside the EU/EEA this year. Monthly cases fell from 29,798 in August to 20,456 in September, but deaths rose from two to 26. The Americas carry most of the burden with 216,594 cases and every reported death, led by Brazil (135,878), then Suriname (16,660), with a September surge in Costa Rica and a locally acquired case in Florida. Asia has reported 47,670 cases, mostly in India (45,402), and Pakistan saw a sharp September rise. In Africa, almost all cases are in Mauritius (6,929). Within Europe, France has 207 locally acquired cases across 30 clusters. Only three new cases last week, down from 22, which reflects the waning vector season. Sixteen clusters remain active, the largest in Prayssac (36) and Cavalaire-sur-Mer (32). Italy has reported one case, in Rome, from a cluster now closed. Switzerland confirmed its first-ever locally acquired cases, four in Ticino.
Dengue, global updates
Globally, more than 2.5 million cases and 1,000 deaths have been reported in 2026 as of October, fewer than in 2025. In the Americas, 1.85 million cases by week 40 are 54% below 2025, with Brazil accounting for most of them (1.37 million). Activity has shifted to Asia. Bangladesh has 114,251 cases and 352 deaths and is still rising. Cambodia is up 137% on last year, Viet Nam up 25%, Sri Lanka up 90%, and India rose 72% month-on-month in September. In Africa, Chad’s outbreak is unusual and growing fast, with 6,275 suspected cases, 353 confirmed and 18 deaths as of 3 November. Those figures doubled in two weeks. It began in a refugee camp in the east and spread to N’Djamena. In Florida, there are 524 locally acquired cases as of 31 October, the largest U.S. outbreak in decades. Most are in Hillsborough (407), and one death has been confirmed., In Europe, Italy has 76 local cases and France eight. No new cases were reported last week, but seven clusters remain active.
Extensively drug-resistant typhoid (XDR Salmonella typhi), Senegal
A surge in imported cases of multidrug-resistant typhoid fever has been reported in France as of November 2026. This increase is specifically driven by Salmonella Typhi genotype 2.3.1. Among these imported infections, 57 cases have been linked to travel from Senegal.
Measles, global updates
In September, 66 measles cases were reported form 13 European countries, led by Bulgaria and Italy. Over the past year there were 2,325 cases and no deaths. Portugal has a small outbreak in Lisbon that started from imported cases. Türkiye has reported 1,141 cases and England 1,030. Kosovo has 269. In West Kazakhstan, cases rose 17-fold to 303.
In the United States, cases have reached 5,182, after 13 straight weeks of triple-digit growth, 11% have been hospitalised. The past week was the deadliest of the year, with deaths in New York, Wisconsin and Pennsylvania. At least eight people have died in 2026, while the CDC has confirmed four. The hot spots are Pennsylvania, Wisconsin and Minnesota. The US is expected to lose its elimination status at next week’s PAHO meeting.
Elsewhere, Bangladesh has a major outbreak with 235,475 suspected cases and 1,167 deaths. Africa has reported 1,788 deaths, mostly in the DRC. The Americas have 56,302 cases, led by Guatemala. Mexico is declining, and Canada has declared its outbreak over.
Yellow fever, global updates
Between January 1 and October 12, 2026, 67 confirmed yellow fever cases and 18 deaths were reported across nine countries in the WHO African Region. Recent activity is concentrated in West Africa, notably in Côte d'Ivoire (30 cases, 10 deaths), Burkina Faso (15 cases, 3 deaths), Ghana (4 cases, 3 deaths), and Liberia (1 case). WHO assesses the regional risk as moderate due to cross-border movement, competent vectors, and uneven vaccination coverage.
West Nile virus disease, Europe and USA
In Europe, 20 countries have reported 2,029 locally acquired cases across 234 affected areas, with no new areas added this week. Italy (780) and Greece (463) carry most of the burden, followed by France, Spain and Romania. The Netherlands, with 76 cases across 18 areas, is a notable northern presence. ECDC expects only low-level transmission from here. In California, there have been 502 cases and 31 deaths, the highest total since 2017. Of these, 85% were neuroinvasive and the case fatality was 6.2%. Los Angeles County accounts for 293 cases, against 20 in 2025. California makes up 30% of the 1,668 US cases. Transmission is waning on both continents as temperatures fall.
204 locally acquired cases across 29 clusters, plus one isolated case in Rome.
20,986 cases and 26 deaths reported globally in September 2026 across 14 countries.
Over 2.5 million cases and over 1,000 deaths reported globally by October 2026.
More than double 2025 cases reported, with the capital hitting highest monthly total since 2022
470 confirmed cases and three deaths reported in 2026, indicating sustained endemic transmission
Surge in imported multidrug-resistant cases driven by genotype 2.3.1, including 57 from Senegal.
2,325 cases reported in EU/EEA over 12 months; major outbreaks ongoing in Bangladesh and Americas.
Significant 2026 resurgence driven by vaccine refusals, with 5000 cases reported by March.
5,182 confirmed cases and at least 8 state-reported deaths in 2026; 562 hospitalizations.
36 deaths reported in Upper East Region between June 2025 and September 2026.
67 confirmed cases and 18 deaths reported across nine countries since January 2026.
207 total local cases in France; four first-ever locally acquired cases confirmed in Switzerland
76 locally acquired cases in Italy and 8 in France; seven clusters remain active.
2,009 locally acquired human cases reported across 20 European countries during the 2026 season
524 locally acquired cases and one death reported across 12 counties as of October 31.
Cluster linked to cosmetic surgery medical tourism in Jalisco, Mexico during 2025.
502 cases reported in California by October 2026, exceeding all annual totals since 2017.
99 cases among workers at Merca Panamá in Panama City; origin remains under investigation.
Four unlinked laboratory-confirmed human cases with poultry exposure reported in four different provinces
Increasing cases of hemorrhagic fever with renal syndrome reported across multiple regions during 2026.
19 cases linked to dried fish in Saratov, alongside 51 cases in Kurgan Oblast.
Second confirmed case in Mosul in three days, bringing Nineveh's annual total to 22.
Epidemic reaches 6275 suspected cases and 18 deaths across five provinces, straining hospitals.
10,741 confirmed cases and 5,230 deaths in DRC; imported cases in Kenya and Nigeria.
Fatal case reported after hunting near a billabong amid rising 2026 caseload
The ESCMID-AUMC Epi Alert, a strategic collaboration between the ESCMID Emerging Infections Subcommittee and the Center of Tropical Medicine and Travel Medicine of Amsterdam University Medical Center (AUMC) that integrates expertise and resources to advance emerging infectious diseases surveillance and intelligence sharing. This collaboration integrates ESCMID's extensive international network and emerging infections expertise with AUMC's proven surveillance capabilities, led by Dr. Abraham Goorhuis and the AUMC team and other collaborators form European Institutions.
The Epi Alert aims to be a weekly publication. The briefings are curated by infectious disease specialists prioritising data from trusted sources (such as Beacon, H-Radar, Outbreaknews, WHO, ECDC, CDC) based on potential impact, geographic region and urgency/relevancy to clinical practice. It aims to provide concise summaries for busy healthcare professionals with direct links for further investigation and transparency.
This integrated collaboration represents a significant milestone in ESCMID's commitment to emerging infections preparedness, strengthening our collective capacity to detect, analyse, and respond to infectious disease threats through international cooperation.
Disclaimer: The information in this epi-alert is a weekly summary of the information that is available on the internet, mainly the websites of Beacon, H-Radar, Outbreaknews, WHO, ECDC, CDC, and others. For this summary, we consider issues that are most relevant to the ESCMID members involved in clinical patient care. Therefore, this report is not comprehensive, but we strive to include all major global issues in this report on a weekly basis.